<DOC>
	<DOCNO>NCT01796327</DOCNO>
	<brief_summary>This study aim determine proportion study drug dacomitinib PF-00299804 , take digestive tract body give oral tablet compare take intravenous dose .</brief_summary>
	<brief_title>A Study To Assess Absorption Of Study Drug Dacomitinib ( PF-00299804 ) , Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female ( nonchildbearing potential ) subject age 18 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Treatment investigational drug within 3 month 5 halflives precede first dose study medication , whichever longer . Any condition possibly affect drug absorption ( eg , gastrectomy ) . Any known allergy sensitivity drug excipients .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>dacomitinib</keyword>
	<keyword>PF-00299804</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioavailability</keyword>
</DOC>